Target intelligence / Profile preview

Extracellular collagen

Molecular classification
Structural protein, Extracellular matrix protein
01

Overview

Extracellular collagen is the primary structural protein of the extracellular matrix (ECM), providing mechanical strength and scaffolding to connective tissues such as skin, bone, and cartilage (StatPearls, 2023). It consists of three polypeptide chains wound into a triple helix, which further assemble into fibrils and fibers to maintain tissue integrity (UniProt, 2024). Beyond its structural role, collagen serves as a signaling molecule by interacting with cell surface receptors like integrins and discoidin domain receptors (DDRs) to regulate cell adhesion, migration, and differentiation (Nature Reviews Molecular Cell Biology, 2009). In pathological conditions, the dysregulation of collagen metabolism leads to excessive deposition (fibrosis) or degradation, contributing to diseases like pulmonary fibrosis, cirrhosis, and cancer metastasis (Journal of Cell Science, 2011). Therapeutic interventions target collagen through enzymatic degradation, such as collagenase for Dupuytren's contracture, or by inhibiting its synthesis and cross-linking to treat fibrotic disorders (FDA, 2010). Additionally, collagen-based biomaterials are used in regenerative medicine and wound healing to promote tissue repair (Advanced Drug Delivery Reviews, 2003).

Other names
CollagenFibrillar collagenExtracellular matrix collagenInterstitial collagen
02

Mechanism of action

Enzymatic degradation of collagen fibers; Inhibition of collagen synthesis; Inhibition of lysyl oxidase (LOX) to prevent collagen cross-linking; Modulation of TGF-beta signaling to reduce collagen production.

03

Biological functions

Structural supportCell adhesionTissue integritySignal transductionWound healingExtracellular matrix organization
04

Disease associations

FibrosisCancerSclerodermaOsteogenesis imperfectaEhlers-Danlos syndromeArthritisDupuytren contracturePeyronie disease
05

Safety considerations

Tendon ruptureImpaired wound healingHypersensitivity reactionsTissue fragilityInjection site reactions
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Pro-collagen type I N-terminal propeptide (PINP)C-terminal telopeptide of type I collagen (CTX-I)Pro-collagen type III N-terminal propeptide (P3NP)Hydroxyproline

Beyond the preview

Go deeper on Extracellular collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call